AGMB
AgomAb Therapeutics NV American Depositary Shares
NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY
$10.74
+0.94% today
Updated 2026-04-29
Market cap
$528.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.50
Dividend yield
—
52W range
$9 – $17
Volume
0.2M
AgomAb Therapeutics NV American Depositary Shares (AGMB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2025
Consensus EPS estimate
$-41.04
Fiscal period ending
2025-12-31
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.8%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+5.8%
2026-04-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-24 | $-0.42 | — | $10.70 | $11.32 | +5.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.42 | — | — | — |
| 2025-12-31 | $-41.04 | — | — | — | — |
Frequently asked questions
When does AgomAb Therapeutics NV American Depositary Shares report next earnings?
AgomAb Therapeutics NV American Depositary Shares (AGMB) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-41.04.
Has AgomAb Therapeutics NV American Depositary Shares beaten earnings estimates?
AgomAb Therapeutics NV American Depositary Shares has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports.
How does AGMB stock react to earnings?
AGMB stock has moved an average of +5.8% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.